GIOVANNA GIORDANO: Open Payments
NPI 1447701735 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 32 payments from 9 companies in 2025. Trend: 2023 $883 · 2024 $552 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 18 | $307 |
| Lilly USA, LLC | 3 | $58 |
| Novo Nordisk Inc | 3 | $58 |
| Cumberland Pharmaceuticals, Inc. | 1 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| Exact Sciences Corporation | 1 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Kerendia, KRISTALOSE, FARXIGA, JARDIANCE, The Cologuard Plus Collection Kit, Wegovy, EVENITY, MOUNJARO.
Industry payments across TX — which companies pay providers there.
